|

individualized anti-tumor new antigen iNeo-Vac-R01 injection Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1/2: 2

Top Sponsors

  • Zhejiang University2

Indications

  • Cancer2
  • Advanced Hepatocellular Carcinoma (HCC)1
  • Advanced Intrahepatic Cholangiocarcinoma1

Other2 trials

Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma
Phase 1/2
Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.